Related Experiment Video
Updated: Apr 1, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
Hospital systems for the detection and prevention of adverse drug events
1Medication Outcomes Center, Department of Clinical Pharmacy, University of California, San Francisco, San Francisco, California, USA. chengc@pharmacy.ucsf.edu
Abstract:
In its 2006 report "Preventing Medication Errors," the Institute of Medicine (IOM) estimated that more than 1.5 million preventable adverse drug events (ADEs) occur annually in the United States. Many organizations, including the IOM, the Institute for Safe Medication Practices, the US Food and Drug Administration, and the Leap Frog Group for Patient Safety have advocated the implementation of technologies to reduce ADEs, particularly in the hospital setting. Many technologies have emerged in recent years to reduce ADEs at various points in the medication use process; however, interfacing some of these key technologies with existing hospital systems poses significant challenges.
Related Concept Videos
Drug Toxicity: Risk factors
Pharmaceutical Poisoning: Potential Scenarios
Modified-Release Drug Delivery Systems: Stimuli-Activated
Pharmacokinetics: Drug–Drug Interactions
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

